{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:32:02Z","timestamp":1794857522803,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Federal Ministry of Education and Research, Germany","award":["DZL, German Lung Center"],"award-info":[{"award-number":["DZL, German Lung Center"]}]},{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Idiopathic pulmonary fibrosis (IPF) is a diffuse parenchymal lung disease characterized by exuberant deposition of extracellular matrix (ECM) proteins in the lung interstitium, which contributes to substantial morbidity and mortality in IPF patients. Matrix metalloproteinases (MMPs) are a large family of zinc-dependent endopeptidases, many of which have been implicated in the regulation of ECM degradation in lung fibrosis. However, the roles of MMP-2 and -9 (also termed gelatinases A and B) have not yet been explored in lung fibrosis in detail.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>AdTGF-\u03b21 was applied via orotracheal routes to the lungs of WT, MMP-2 KO, MMP-9 KO and MMP-2\/-9 dKO mice on day 0 to induce lung fibrosis. Using hydroxyproline assay, FlexiVent based lung function measurement, histopathology, western blot and ELISA techniques, we analyzed MMP-2 and MMP-9 levels in BAL fluid and lung, collagen contents in lung and lung function in mice on day 14 and 21 post-treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>IPF lung homogenates exhibited significantly increased levels of MMP-2 and MMP-9, relative to disease controls. Enzymatically active MMP-2 and MMP-9 was increased in lungs of mice exposed to adenoviral TGF-\u03b21, suggesting a role for these metalloproteinases in lung fibrogenesis. However, we found that neither MMP-2 or MMP-9 nor combined MMP-2\/-9 deletion had any effect on experimental lung fibrosis in mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Together, our data strongly suggest that both gelatinases MMP-2 and MMP-9 play only a subordinate role in experimental lung fibrosis in mice.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-022-02105-7","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T16:06:48Z","timestamp":1657296408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Role of matrix metalloprotease-2 and MMP-9 in experimental lung fibrosis in mice"],"prefix":"10.1186","volume":"23","author":[{"given":"Tina","family":"Bormann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Maus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Stolper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Tort Tarr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Brandenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Wedekind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Jonigk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Welte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Gauldie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich A.","family":"Maus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"issue":"3","key":"2105_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1183\/09031936.00185114","volume":"46","author":"J Hutchinson","year":"2015","unstructured":"Hutchinson J, Fogarty A, Hubbard R, McKeever T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J. 2015;46(3):795\u2013806.","journal-title":"Eur Respir J"},{"issue":"6","key":"2105_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788\u2013824.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9807","key":"2105_CR3","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","volume":"378","author":"TE King Jr","year":"2011","unstructured":"King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011;378(9807):1949\u201361.","journal-title":"Lancet"},{"key":"2105_CR4","doi-asserted-by":"crossref","unstructured":"American Thoracic Society, European Respiratory Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000;161(2 Pt 1):646\u201364.","DOI":"10.1164\/ajrccm.161.2.ats3-00"},{"issue":"8","key":"2105_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","volume":"92","author":"R Visse","year":"2003","unstructured":"Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92(8):827\u201339.","journal-title":"Circ Res"},{"issue":"3","key":"2105_CR6","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1432-1033.1997.00751.x","volume":"250","author":"MP d'Ortho","year":"1997","unstructured":"d\u2019Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, et al. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem. 1997;250(3):751\u20137.","journal-title":"Eur J Biochem"},{"issue":"8","key":"2105_CR7","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.4049\/jimmunol.1201043","volume":"190","author":"VJ Craig","year":"2013","unstructured":"Craig VJ, Quintero PA, Fyfe SE, Patel AS, Knolle MD, Kobzik L, et al. Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury. J Immunol. 2013;190(8):4283\u201396.","journal-title":"J Immunol"},{"issue":"12","key":"2105_CR8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","volume":"15","author":"C Bonnans","year":"2014","unstructured":"Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014;15(12):786\u2013801.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2105_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12931-016-0343-6","volume":"17","author":"A Pardo","year":"2016","unstructured":"Pardo A, Cabrera S, Maldonado M, Selman M. Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis. Respir Res. 2016;17:23.","journal-title":"Respir Res"},{"issue":"2","key":"2105_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1101\/gad.14.2.163","volume":"14","author":"Q Yu","year":"2000","unstructured":"Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000;14(2):163\u201376.","journal-title":"Genes Dev"},{"issue":"11","key":"2105_CR11","doi-asserted-by":"publisher","first-page":"L1006","DOI":"10.1152\/ajplung.00015.2014","volume":"306","author":"T Kobayashi","year":"2014","unstructured":"Kobayashi T, Kim H, Liu X, Sugiura H, Kohyama T, Fang Q, et al. Matrix metalloproteinase-9 activates TGF-\u03b2 and stimulates fibroblast contraction of collagen gels. Am J Physiol Lung Cell Mol Physiol. 2014;306(11):L1006\u201315.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"2105_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1242\/dmm.012062","volume":"7","author":"M Giannandrea","year":"2014","unstructured":"Giannandrea M, Parks WC. Diverse functions of matrix metalloproteinases during fibrosis. Dis Model Mech. 2014;7(2):193\u2013203.","journal-title":"Dis Model Mech"},{"issue":"12","key":"2105_CR13","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.biocel.2007.06.022","volume":"39","author":"S Cabrera","year":"2007","unstructured":"Cabrera S, Gaxiola M, Arreola JL, Ram\u00edrez R, Jara P, D\u2019Armiento J, et al. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin. Int J Biochem Cell Biol. 2007;39(12):2324\u201338.","journal-title":"Int J Biochem Cell Biol"},{"issue":"8","key":"2105_CR14","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/labinvest.2011.80","volume":"91","author":"G Ram\u00edrez","year":"2011","unstructured":"Ram\u00edrez G, Hagood JS, Sanders Y, Ram\u00edrez R, Becerril C, Segura L, et al. Absence of Thy-1 results in TGF-\u03b2 induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts. Lab Investig. 2011;91(8):1206\u201318.","journal-title":"Lab Investig."},{"issue":"9","key":"2105_CR15","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1164\/rccm.201001-0028OC","volume":"182","author":"C Garcia-de-Alba","year":"2010","unstructured":"Garcia-de-Alba C, Becerril C, Ruiz V, Gonzalez Y, Reyes S, Garcia-Alvarez J, et al. Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing. Am J Respir Crit Care Med. 2010;182(9):1144\u201352.","journal-title":"Am J Respir Crit Care Med"},{"key":"2105_CR16","doi-asserted-by":"crossref","unstructured":"Todd JL, Vinisko R, Liu Y, Neely ML, Overton R, Flaherty KR, et al. Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort. BMC Pulm Med. 2020;20.","DOI":"10.1186\/s12890-020-1103-4"},{"issue":"1","key":"2105_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1183\/09031936.00060708","volume":"33","author":"S McKeown","year":"2009","unstructured":"McKeown S, Richter AG, O\u2019Kane C, McAuley DF, Thickett DR. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur Respir J. 2009;33(1):77\u201384.","journal-title":"Eur Respir J"},{"issue":"3","key":"2105_CR18","doi-asserted-by":"publisher","first-page":"L562","DOI":"10.1152\/ajplung.2000.279.3.L562","volume":"279","author":"M Selman","year":"2000","unstructured":"Selman M, Ruiz V, Cabrera S, Segura L, Ramirez R, Barrios R, et al. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol. 2000;279(3):L562\u201374.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"2105_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171344","volume":"12","author":"J Guiot","year":"2017","unstructured":"Guiot J, Henket M, Corhay JL, Moermans C, Louis R. Sputum biomarkers in IPF: evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7. PLoS ONE. 2017;12(2): e0171344.","journal-title":"PLoS ONE"},{"issue":"36","key":"2105_CR20","doi-asserted-by":"publisher","first-page":"22389","DOI":"10.1074\/jbc.272.36.22389","volume":"272","author":"T Itoh","year":"1997","unstructured":"Itoh T, Ikeda T, Gomi H, Nakao S, Suzuki T, Itohara S. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J Biol Chem. 1997;272(36):22389\u201392.","journal-title":"J Biol Chem"},{"issue":"3","key":"2105_CR21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0092-8674(00)81169-1","volume":"93","author":"TH Vu","year":"1998","unstructured":"Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, et al. MMP-9\/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 1998;93(3):411\u201322.","journal-title":"Cell"},{"issue":"4","key":"2105_CR22","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1172\/JCI119590","volume":"100","author":"PJ Sime","year":"1997","unstructured":"Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest. 1997;100(4):768\u201376.","journal-title":"J Clin Invest"},{"issue":"11","key":"2105_CR23","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1084\/jem.20120983","volume":"209","author":"K Steinwede","year":"2012","unstructured":"Steinwede K, Henken S, Bohling J, Maus R, Ueberberg B, Brumshagen C, et al. TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice. J Exp Med. 2012;209(11):1937\u201352.","journal-title":"J Exp Med"},{"issue":"3","key":"2105_CR24","doi-asserted-by":"publisher","first-page":"L377","DOI":"10.1152\/ajplung.00024.2020","volume":"320","author":"T Bormann","year":"2021","unstructured":"Bormann T, Maus R, Stolper J, Jonigk D, Welte T, Gauldie J, et al. Role of the COX2-PGE2 axis in S. pneumoniae-induced exacerbation of experimental fibrosis. Am J Physiol Lung Cell Mol Physiol. 2021;320(3):L377\u201392.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"9","key":"2105_CR25","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.4049\/jimmunol.1900980","volume":"204","author":"S Moy\u00e9","year":"2020","unstructured":"Moy\u00e9 S, Bormann T, Maus R, Sparwasser T, Sandrock I, Prinz I, et al. Regulatory T cells limit pneumococcus-induced exacerbation of lung fibrosis in mice. J Immunol. 2020;204(9):2429\u201338.","journal-title":"J Immunol"},{"issue":"7","key":"2105_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/thoraxjnl-2014-206420","volume":"70","author":"S Knippenberg","year":"2015","unstructured":"Knippenberg S, Ueberberg B, Maus R, Bohling J, Ding N, Tort Tarres M, et al. Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin. Thorax. 2015;70(7):636\u201346.","journal-title":"Thorax"},{"issue":"10","key":"2105_CR27","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1136\/thoraxjnl-2018-212603","volume":"74","author":"M Tort Tarres","year":"2019","unstructured":"Tort Tarres M, Aschenbrenner F, Maus R, Stolper J, Schuette L, Knudsen L, et al. The FMS-like tyrosine kinase-3 ligand\/lung dendritic cell axis contributes to regulation of pulmonary fibrosis. Thorax. 2019;74(10):947\u201357.","journal-title":"Thorax"},{"issue":"11","key":"2105_CR28","doi-asserted-by":"publisher","first-page":"L1260","DOI":"10.1152\/ajplung.00065.2016","volume":"310","author":"E Lopez-Rodriguez","year":"2016","unstructured":"Lopez-Rodriguez E, Boden C, Echaide M, Perez-Gil J, Kolb M, Gauldie J, et al. Surfactant dysfunction during overexpression of TGF-\u03b21 precedes profibrotic lung remodeling in vivo. Am J Physiol Lung Cell Mol Physiol. 2016;310(11):L1260\u201371.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"2105_CR29","first-page":"1241","volume":"149","author":"T Hayashi","year":"1996","unstructured":"Hayashi T, Stetler-Stevenson WG, Fleming MV, Fishback N, Koss MN, Liotta LA, et al. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol. 1996;149(4):1241\u201356.","journal-title":"Am J Pathol"},{"issue":"6","key":"2105_CR30","first-page":"687","volume":"78","author":"Y Fukuda","year":"1998","unstructured":"Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest. 1998;78(6):687\u201398.","journal-title":"Lab Invest"},{"issue":"3","key":"2105_CR31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4103\/0970-2113.83972","volume":"28","author":"A Mishra","year":"2011","unstructured":"Mishra A, Bhattacharya P, Paul S, Paul R, Swarnakar S. An alternative therapy for idiopathic pulmonary fibrosis by doxycycline through matrix metalloproteinase inhibition. Lung India. 2011;28(3):174\u20139.","journal-title":"Lung India"},{"issue":"11","key":"2105_CR32","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1089\/gtmb.2015.0057","volume":"19","author":"HT Zhang","year":"2015","unstructured":"Zhang HT, Fang SC, Wang CY, Wang W, Wu J, Wang C, et al. MMP-9 1562C>T gene polymorphism and efficacy of glucocorticoid therapy in idiopathic pulmonary fibrosis patients. Genet Test Mol Biomarkers. 2015;19(11):591\u20137.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"4","key":"2105_CR33","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/path.826","volume":"193","author":"M Corbel","year":"2001","unstructured":"Corbel M, Caulet-Maugendre S, Germain N, Molet S, Lagente V, Boichot E. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. J Pathol. 2001;193(4):538\u201345.","journal-title":"J Pathol"},{"issue":"1","key":"2105_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3349\/ymj.2009.50.1.68","volume":"50","author":"JY Kim","year":"2009","unstructured":"Kim JY, Choeng HC, Ahn C, Cho SH. Early and late changes of MMP-2 and MMP-9 in bleomycin-induced pulmonary fibrosis. Yonsei Med J. 2009;50(1):68\u201377.","journal-title":"Yonsei Med J"},{"key":"2105_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108851","volume":"114","author":"L Yang","year":"2019","unstructured":"Yang L, Chen PP, Luo M, Shi WL, Hou DS, Gao Y, et al. Inhibitory effects of total ginsenoside on bleomycin-induced pulmonary fibrosis in mice. Biomed Pharmacother. 2019;114: 108851.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"2105_CR36","first-page":"317","volume":"50","author":"T Oggionni","year":"2006","unstructured":"Oggionni T, Morbini P, Inghilleri S, Palladini G, Tozzi R, Vitulo P, et al. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis. Eur J Histochem. 2006;50(4):317\u201325.","journal-title":"Eur J Histochem"},{"issue":"1","key":"2105_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1165\/rcmb.2002-0166TR","volume":"28","author":"JJ Atkinson","year":"2003","unstructured":"Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol. 2003;28(1):12\u201324.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"2105_CR38","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/019021490944232","volume":"31","author":"S Chakrabarti","year":"2005","unstructured":"Chakrabarti S, Patel KD. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res. 2005;31(6):599\u2013621.","journal-title":"Exp Lung Res"},{"issue":"14","key":"2105_CR39","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1096\/fj.04-2445com","volume":"18","author":"J Esparza","year":"2004","unstructured":"Esparza J, Kruse M, Lee J, Michaud M, Madri JA. MMP-2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP-9 expression and activity. Faseb j. 2004;18(14):1682\u201391.","journal-title":"Faseb j"},{"issue":"5","key":"2105_CR40","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ceb.2004.07.010","volume":"16","author":"JD Mott","year":"2004","unstructured":"Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol. 2004;16(5):558\u201364.","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"2105_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1183\/09031936.00146510","volume":"38","author":"S L\u00f6ffek","year":"2011","unstructured":"L\u00f6ffek S, Schilling O, Franzke CW. Series \u201cmatrix metalloproteinases in lung health and disease\u201d: biological role of matrix metalloproteinases: a critical balance. Eur Respir J. 2011;38(1):191\u2013208.","journal-title":"Eur Respir J"},{"issue":"2","key":"2105_CR42","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0002-9440(10)64563-4","volume":"157","author":"T Betsuyaku","year":"2000","unstructured":"Betsuyaku T, Fukuda Y, Parks WC, Shipley JM, Senior RM. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am J Pathol. 2000;157(2):525\u201335.","journal-title":"Am J Pathol"},{"key":"2105_CR43","first-page":"PA1903","volume":"46","author":"A Tomaru","year":"2015","unstructured":"Tomaru A, Gabazza E, Kobayashi T, Kobayashi H, Taguchi O, Takagi T, et al. Matrix metalloproteinase-2 is protective in bleomycin-induced pulmonary fibrosis. Eur Respir J. 2015;46:PA1903.","journal-title":"Eur Respir J"},{"issue":"1","key":"2105_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bbrc.2011.02.012","volume":"406","author":"I Onozuka","year":"2011","unstructured":"Onozuka I, Kakinuma S, Kamiya A, Miyoshi M, Sakamoto N, Kiyohashi K, et al. Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice. Biochem Biophys Res Commun. 2011;406(1):134\u201340.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2105_CR45","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s10620-010-1296-0","volume":"56","author":"BD Radbill","year":"2011","unstructured":"Radbill BD, Gupta R, Ramirez MC, DiFeo A, Martignetti JA, Alvarez CE, et al. Loss of matrix metalloproteinase-2 amplifies murine toxin-induced liver fibrosis by upregulating collagen I expression. Dig Dis Sci. 2011;56(2):406\u201316.","journal-title":"Dig Dis Sci"},{"issue":"8","key":"2105_CR46","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/labinvest.2012.68","volume":"92","author":"X Du","year":"2012","unstructured":"Du X, Shimizu A, Masuda Y, Kuwahara N, Arai T, Kataoka M, et al. Involvement of matrix metalloproteinase-2 in the development of renal interstitial fibrosis in mouse obstructive nephropathy. Lab Invest. 2012;92(8):1149\u201360.","journal-title":"Lab Invest"},{"issue":"12","key":"2105_CR47","doi-asserted-by":"publisher","first-page":"e0143390","DOI":"10.1371\/journal.pone.0143390","volume":"10","author":"MK Tveitar\u00e5s","year":"2015","unstructured":"Tveitar\u00e5s MK, Skogstrand T, Leh S, Helle F, Iversen BM, Chatziantoniou C, et al. Matrix metalloproteinase-2 knockout and heterozygote mice are protected from hydronephrosis and kidney fibrosis after unilateral ureteral obstruction. PLoS ONE. 2015;10(12):e0143390.","journal-title":"PLoS ONE"},{"issue":"9","key":"2105_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198464","volume":"13","author":"DV Hingorani","year":"2018","unstructured":"Hingorani DV, Lippert CN, Crisp JL, Savariar EN, Hasselmann JPC, Kuo C, et al. Impact of MMP-2 and MMP-9 enzyme activity on wound healing, tumor growth and RACPP cleavage. PLoS ONE. 2018;13(9): e0198464.","journal-title":"PLoS ONE"},{"key":"2105_CR49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.neuroscience.2012.03.036","volume":"212","author":"Y Suofu","year":"2012","unstructured":"Suofu Y, Clark JF, Broderick JP, Kurosawa Y, Wagner KR, Lu A. Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion. Neuroscience. 2012;212:180\u20139.","journal-title":"Neuroscience"},{"issue":"5","key":"2105_CR50","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.4049\/jimmunol.169.5.2643","volume":"169","author":"T Itoh","year":"2002","unstructured":"Itoh T, Matsuda H, Tanioka M, Kuwabara K, Itohara S, Suzuki R. The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J Immunol. 2002;169(5):2643\u20137.","journal-title":"J Immunol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02105-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02105-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02105-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T16:07:38Z","timestamp":1657296458000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02105-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2105"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02105-7","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"6 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was designed and performed in accordance with the Declaration of Helsinki following the requirements of the local ethics committee at MHH (ethics vote no. 2702-2015). All animal experiments were done in accordance with the German Animal Welfare Legislation and approved by the local Institutional Animal Care and Research Advisory Committee and permitted by the Lower Saxony State Office for Consumer Protection and Food Safety (reference number 16\/2249).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declares that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"180"}}